Addex Therapeutics Ltd (ADXN)
8.60
-0.04
(-0.46%)
USD |
NASDAQ |
May 31, 16:00
8.39
-0.21
(-2.44%)
After-Hours: 20:00
Addex Therapeutics Revenue (Annual): 1.796M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.796M |
| December 31, 2022 | 1.492M |
| December 31, 2021 | 3.191M |
| December 31, 2020 | 3.854M |
| December 31, 2019 | 2.781M |
| December 31, 2018 | 6.178M |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 |
| Date | Value |
|---|---|
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | 3.196M |
| December 31, 2010 | 1.887M |
| December 31, 2009 | 3.779M |
| December 31, 2008 | 24.82M |
| December 31, 2007 | 0.4061M |
| December 31, 2006 | 3.785M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.492M
Minimum
2022
3.854M
Maximum
2020
2.623M
Average
2.781M
Median
2019
Revenue (Annual) Benchmarks
| AC Immune SA | 16.48M |
| CRISPR Therapeutics AG | 370.00M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 7.838M |
| MoonLake Immunotherapeutics | -- |